The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Tenofovir disoproxil fumarate (TDF) is active against both HBV and HIV. Whether the introduction of TDF‐containing combination antiretroviral therapy (cART) has improved the outcome of HIV/HBV‐coinfected patients remains unclear in areas of higher HBV endemicity.
Methods
We retrospectively reviewed medical records of newly diagnosed antiretroviral‐naïve HIV‐infected patients between...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.